Connect:        


Stock Chart (NASDAQ: IPCI)
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote (NASDAQ: IPCI)
Intellipharmaceutics
Price: 2.60
Change: + 0.19
Day High: 2.62
Day Low: 2.41
Volume: 187,175
Delayed at least 20 minutes.
Provided by eSignal.

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The Company’s patented Hypermatrix™ technology is a multidimensional controlled-release drug delivery platform that can be applied to the efficient development of a wide range of existing and new pharmaceuticals. Based on this technology, Intellipharmaceutics has a pipeline of product candidates in various stages of development, including eight ANDAs as having been filed with the FDA, in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract, diabetes, pain.

Recent Press Releases

Mar 16, 2017
Intellipharmaceutics Announces TSX Trading Symbol Change to "IPCI"

Feb 24, 2017
Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage® XR

View all releases »

NASDAQ TSX